Investigating a new heart valve material to improve treatment for aortic stenosis
The pulmonary visceral pleura (PVP) aortic valve
This study is testing a new type of heart valve made from a special material to see if it lasts longer and works better than the usual animal-based valves for people with aortic stenosis, which could lead to fewer problems and better health for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-11050723 on NIH RePORTER |
What this research studies
This research focuses on developing a new bioprosthetic valve material derived from the pulmonary visceral pleura (PVP) to address the challenges of aortic stenosis, a condition where the aortic valve narrows and impairs blood flow. The study aims to evaluate the durability and performance of PVP-based valves compared to traditional bovine or porcine pericardial valves, particularly in terms of resistance to calcification and mechanical stress. By utilizing advanced 3D modeling and animal experiments, the research seeks to understand how this new material can enhance valve longevity and patient outcomes. Patients may benefit from improved valve performance and reduced complications associated with current treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with aortic stenosis who may require valve replacement.
Not a fit: Patients with aortic stenosis who are not candidates for valve replacement or those with other significant comorbidities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more durable heart valves that significantly improve the quality of life for patients with aortic stenosis.
How similar studies have performed: Previous research has shown promising results with the use of alternative bioprosthetic materials, indicating potential for success with this novel approach.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Luo, Haoxiang — Vanderbilt University
- Study coordinator: Luo, Haoxiang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.